Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy

Ombretta Turriziani, Nicola Gianotti, Francesca Falasca, Arianna Boni, Anna Rita Vestri, Alice Zoccoli, Adriano Lazzarin, Guido Antonelli

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The aim of the study was to evaluate the mRNA expression of four relevant ABC-transporter genes [MDR1 (P-glycoprotein; Pgp), MRP1, MRP4, and MRP5] in HIV-positive individuals failing treatment and analyze the association between the levels of their expression and viral load, CD4 cell count, and therapeutic history. Ninety-eight HIV-positive samples and 20 samples from healthy donors were analyzed, retrospectively. Peripheral blood mononuclear cells (PBMCs) from HIV1-positive individuals were collected at the time of virological failure. Expression of mRNA of Pgp, MRP1, MRP4, and MRP5 in PBMCs was evaluated by real-time PCR. A high inter-individual variability was observed in both HIV-positive individuals and healthy donors but the expression levels of all mRNA analyzed were significantly higher in the HIV-infected group (P <0.05). A weak but significant inverse correlation was observed between CD4 cell counts and expression levels of MRP4 and MRP5. Comparison of mRNA expression between individuals with different therapeutic histories showed that expression of MRP4 and MRP5 genes in patients who were both protease inhibitor (PI) and non-nucleoside reverse transcriptase inhibitor (NNRTI)-experienced was significantly higher than in patients who were PI experienced but NNRTI-naïve. In conclusion, the mRNA expression of Pgp, MRP1, MRP4, and MRP5 varies among HIV-infected patients and healthy donors but is significantly higher in HIV-positive patients than in donors. The expression of MRP4 and MRP5 seems to correlate with CD4 cell counts. The same protein seems to be overexpressed in patients receiving NNRTIs.

Original languageEnglish
Pages (from-to)766-771
Number of pages6
JournalJournal of Medical Virology
Volume80
Issue number5
DOIs
Publication statusPublished - May 2008

Fingerprint

Blood Cells
HIV
CD4 Lymphocyte Count
Messenger RNA
Tissue Donors
Reverse Transcriptase Inhibitors
Protease Inhibitors
Therapeutics
ATP-Binding Cassette Transporters
P-Glycoprotein
Viral Load
Genes
Real-Time Polymerase Chain Reaction
History
Proteins

Keywords

  • Antiretroviral therapy
  • CD4
  • HIV infection
  • Multidrug resistance gene 1
  • Multidrug resistance-associated proteins
  • Viral load

ASJC Scopus subject areas

  • Virology

Cite this

Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy. / Turriziani, Ombretta; Gianotti, Nicola; Falasca, Francesca; Boni, Arianna; Vestri, Anna Rita; Zoccoli, Alice; Lazzarin, Adriano; Antonelli, Guido.

In: Journal of Medical Virology, Vol. 80, No. 5, 05.2008, p. 766-771.

Research output: Contribution to journalArticle

Turriziani, Ombretta ; Gianotti, Nicola ; Falasca, Francesca ; Boni, Arianna ; Vestri, Anna Rita ; Zoccoli, Alice ; Lazzarin, Adriano ; Antonelli, Guido. / Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy. In: Journal of Medical Virology. 2008 ; Vol. 80, No. 5. pp. 766-771.
@article{08f1994733dd4b4ab1d217611da1f786,
title = "Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy",
abstract = "The aim of the study was to evaluate the mRNA expression of four relevant ABC-transporter genes [MDR1 (P-glycoprotein; Pgp), MRP1, MRP4, and MRP5] in HIV-positive individuals failing treatment and analyze the association between the levels of their expression and viral load, CD4 cell count, and therapeutic history. Ninety-eight HIV-positive samples and 20 samples from healthy donors were analyzed, retrospectively. Peripheral blood mononuclear cells (PBMCs) from HIV1-positive individuals were collected at the time of virological failure. Expression of mRNA of Pgp, MRP1, MRP4, and MRP5 in PBMCs was evaluated by real-time PCR. A high inter-individual variability was observed in both HIV-positive individuals and healthy donors but the expression levels of all mRNA analyzed were significantly higher in the HIV-infected group (P <0.05). A weak but significant inverse correlation was observed between CD4 cell counts and expression levels of MRP4 and MRP5. Comparison of mRNA expression between individuals with different therapeutic histories showed that expression of MRP4 and MRP5 genes in patients who were both protease inhibitor (PI) and non-nucleoside reverse transcriptase inhibitor (NNRTI)-experienced was significantly higher than in patients who were PI experienced but NNRTI-na{\"i}ve. In conclusion, the mRNA expression of Pgp, MRP1, MRP4, and MRP5 varies among HIV-infected patients and healthy donors but is significantly higher in HIV-positive patients than in donors. The expression of MRP4 and MRP5 seems to correlate with CD4 cell counts. The same protein seems to be overexpressed in patients receiving NNRTIs.",
keywords = "Antiretroviral therapy, CD4, HIV infection, Multidrug resistance gene 1, Multidrug resistance-associated proteins, Viral load",
author = "Ombretta Turriziani and Nicola Gianotti and Francesca Falasca and Arianna Boni and Vestri, {Anna Rita} and Alice Zoccoli and Adriano Lazzarin and Guido Antonelli",
year = "2008",
month = "5",
doi = "10.1002/jmv.21152",
language = "English",
volume = "80",
pages = "766--771",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy

AU - Turriziani, Ombretta

AU - Gianotti, Nicola

AU - Falasca, Francesca

AU - Boni, Arianna

AU - Vestri, Anna Rita

AU - Zoccoli, Alice

AU - Lazzarin, Adriano

AU - Antonelli, Guido

PY - 2008/5

Y1 - 2008/5

N2 - The aim of the study was to evaluate the mRNA expression of four relevant ABC-transporter genes [MDR1 (P-glycoprotein; Pgp), MRP1, MRP4, and MRP5] in HIV-positive individuals failing treatment and analyze the association between the levels of their expression and viral load, CD4 cell count, and therapeutic history. Ninety-eight HIV-positive samples and 20 samples from healthy donors were analyzed, retrospectively. Peripheral blood mononuclear cells (PBMCs) from HIV1-positive individuals were collected at the time of virological failure. Expression of mRNA of Pgp, MRP1, MRP4, and MRP5 in PBMCs was evaluated by real-time PCR. A high inter-individual variability was observed in both HIV-positive individuals and healthy donors but the expression levels of all mRNA analyzed were significantly higher in the HIV-infected group (P <0.05). A weak but significant inverse correlation was observed between CD4 cell counts and expression levels of MRP4 and MRP5. Comparison of mRNA expression between individuals with different therapeutic histories showed that expression of MRP4 and MRP5 genes in patients who were both protease inhibitor (PI) and non-nucleoside reverse transcriptase inhibitor (NNRTI)-experienced was significantly higher than in patients who were PI experienced but NNRTI-naïve. In conclusion, the mRNA expression of Pgp, MRP1, MRP4, and MRP5 varies among HIV-infected patients and healthy donors but is significantly higher in HIV-positive patients than in donors. The expression of MRP4 and MRP5 seems to correlate with CD4 cell counts. The same protein seems to be overexpressed in patients receiving NNRTIs.

AB - The aim of the study was to evaluate the mRNA expression of four relevant ABC-transporter genes [MDR1 (P-glycoprotein; Pgp), MRP1, MRP4, and MRP5] in HIV-positive individuals failing treatment and analyze the association between the levels of their expression and viral load, CD4 cell count, and therapeutic history. Ninety-eight HIV-positive samples and 20 samples from healthy donors were analyzed, retrospectively. Peripheral blood mononuclear cells (PBMCs) from HIV1-positive individuals were collected at the time of virological failure. Expression of mRNA of Pgp, MRP1, MRP4, and MRP5 in PBMCs was evaluated by real-time PCR. A high inter-individual variability was observed in both HIV-positive individuals and healthy donors but the expression levels of all mRNA analyzed were significantly higher in the HIV-infected group (P <0.05). A weak but significant inverse correlation was observed between CD4 cell counts and expression levels of MRP4 and MRP5. Comparison of mRNA expression between individuals with different therapeutic histories showed that expression of MRP4 and MRP5 genes in patients who were both protease inhibitor (PI) and non-nucleoside reverse transcriptase inhibitor (NNRTI)-experienced was significantly higher than in patients who were PI experienced but NNRTI-naïve. In conclusion, the mRNA expression of Pgp, MRP1, MRP4, and MRP5 varies among HIV-infected patients and healthy donors but is significantly higher in HIV-positive patients than in donors. The expression of MRP4 and MRP5 seems to correlate with CD4 cell counts. The same protein seems to be overexpressed in patients receiving NNRTIs.

KW - Antiretroviral therapy

KW - CD4

KW - HIV infection

KW - Multidrug resistance gene 1

KW - Multidrug resistance-associated proteins

KW - Viral load

UR - http://www.scopus.com/inward/record.url?scp=41849088833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41849088833&partnerID=8YFLogxK

U2 - 10.1002/jmv.21152

DO - 10.1002/jmv.21152

M3 - Article

VL - 80

SP - 766

EP - 771

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 5

ER -